Patent Assignment
Reel/Frame 028320/0312
Release of Security Interest
Recorded: 2012-06-05
Pages: 14
Assignor
INVESTISSEMENT QUEBEC
Executed: 2012-04-12
Assignee
GEMIN X PHARMACEUTICALS CANADA INC.
3576 AVENUE DU PARC, SUITE 4310, MONTREAL, QUEBEC, H2X 2H7, CANADA
Covered Properties
(20)
Composition and Methods for Modulating the Length of Telomeres
Patent:
6,294,332 →
Application:
09/214,178 →
Pyrrole-Type Compounds, Compositions, and Methods for Treating Cancer or Viral Diseases
Patent:
6,407,244 →
Application:
09/491,712 →
Methods for Monitoring the Binding of A1/UP1 to Single-Stranded Nucleic Acid Sequences, and to Measure the Effect of This Binding on Telomere Extension and Protection
Patent:
6,358,687 →
Application:
09/536,259 →
Pyrrole-Type Compounds, Compositions, and Methods for Treating Cancer or Viral Diseases
Pyrrole-Type compounds, compositions, and methods for treating cancer or viral diseases
Application:
10/392,202 →
Publication:
US 2004/0014987
Pyrrole-Type Compounds, Compositions, and Methods for Treating Cancer, Treating Viral Diseases and Causing Immunosuppression
Diterpenoid Compounds, Compositions Thereof and Their Use as Anti-Cancer or Anti-Fungal Agents
Triheterocyclic Compounds, Compositions, and Methods for Treating Cancer or Viral Diseases
Diterpenoid Compounds, Compositions Thereof and Their Use as Anti-Cancer or Anti-Fungal Agents
Methods and compositions relating to hnRNP A1, A1B, A2, and B1 nucleic acid molecules
Application:
10/943,441 →
Publication:
US 2005/0153918
Pyrrole-Type Compounds, Compositions and Methods for Treating Cancer or Viral Disease
Dipyrrole Compounds, Compositions, and Methods for Treating Cancer or Viral Diseases
Methods for treating or preventing anemia or thrombocytopenia using a triheterocyclic compound
Application:
11/825,194 →
Publication:
US 2008/0051400
Methods for treating arthritis using triheterocyclic compounds
Application:
11/895,012 →
Publication:
US 2008/0076739
Triheterocyclic Compounds and Compositions Thereof
Application:
12/176,123 →
Publication:
US 2008/0318902
Methods for Treating Cancer
Compositions and Methods for Effecting Nad+ Levels Using a Nicotinamide Phosphoribosyl Tranferase Inhibitor
Compositions and Methods for Effecting Nad+ Levels Using a Nicotinamide Phosphoribosyl Transferase Inhibitor
Triheterocyclic Compounds and Compositions Thereof
Methods for Effecting Nad+ Levels Using Pyridyl Cyanoguanidines and Prodrugs Thereof
Application:
60/975,488 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jul 19, 2004
From: GEMINX BIOTECHNOLOGIES, INC.
To: INVESTISSEMENT QUEBEC
Reel/Frame 015579/0253 →
Assignment of Assignor's Interest
Jul 26, 2004
From: SHORE, GORDON C.; MURTHY, MADIRAJU S.R.; ATTARDO, GIORGIO; JOHNSON, ROY A.
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 015613/0324 →
Assignment of Assignor's Interest
Sep 28, 2004
From: ATTARDO, GIORGIO; DAIRI, KENZA; LAVALLEE, JEAN-FRANCOIS; RIOUX, ELISE
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 015835/0489 →
Assignment of Assignor's Interest
Oct 12, 2004
From: LAVALLEE, JEAN-FRANCOIS; RIOUX, ELISE; RABOUIN, DANIEL; DOYLE, TERRENCE W.
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 015882/0557 →
Assignment of Assignor's Interest
Oct 26, 2004
From: STAFFORD, ANGELA M.; UBILLAS, ROSA; MCALPINE, JAMES B.
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 015920/0258 →
Assignment of Assignor's Interest
Oct 26, 2004
From: BEAUPARLANT, PIERRE; ATTARDO, GIORGIO; ZHANG, ZHIYING; LAVALLEE, JEAN-FRANCOIS
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 015917/0780 →
Assignment of Assignor's Interest
Dec 28, 2004
From: GEMIN X BIOTECHNOLOGIES INC.
To: GALILEO PHARMACEUTICALS, INC.
Reel/Frame 016113/0779 →
Assignment of Assignor's Interest
Mar 25, 2005
From: CHABOT, BENOIT; BOUCHARD, LOUISE; LABRECQUE, PASCALE; PATRY, CAROLINE
To: TELOGENE, INC.
Reel/Frame 015961/0876 →
Assignment of Assignor's Interest
Oct 21, 2005
From: FORTIN, SAMUEL
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 017119/0707 →
Assignment of Assignor's Interest
Nov 21, 2005
From: MURTHY, MADIRAJU S.R.; STEENAART, NANCY A.E.; SHORE, GORDON C.; JOHNSON, ROY A.
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 017044/0574 →
Security Agreement
Dec 22, 2005
From: GALILEO PHARMACEUTICALS, INC.
To: ALLOY VENTURES, INC.
Reel/Frame 016936/0079 →
Assignment of Assignor's Interest
Jun 27, 2006
From: ATTARDO, GIORGIO
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 017869/0358 →
Security Agreement
Sep 5, 2006
From: GEMIN X BIOTECHNOLOGIES INC.
To: INVESTISSEMENT QUEBEC
Reel/Frame 018275/0714 →
Assignment of Assignor's Interest
Jan 10, 2007
From: TELOGENE INC.
To: INVESTISSEMENT QUEBEC
Reel/Frame 018767/0976 →
Assignment of Assignor's Interest
Nov 7, 2007
From: O'BRIEN, SUSAN
To: TEXAS SYSTEMS BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 020086/0263 →
Assignment of Assignor's Interest
Nov 15, 2007
From: VIALLET, JEAN
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 020129/0362 →
Assignment of Assignor's Interest
Nov 15, 2007
From: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 020129/0285 →
Assignment of Assignor's Interest
Nov 15, 2007
From: VIALLET, JEAN
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 020129/0298 →
Assignment of Assignor's Interest
Nov 19, 2007
From: VIALLET, JEAN
To: GEMIN X BIOTECHNOLOGIES INC.
Reel/Frame 020130/0563 →
Change of Name
Jan 31, 2008
From: BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
To: GEMIN X PHARMACEUTICALS CANADA INC.
Reel/Frame 020450/0261 →
Change of Name
Jan 31, 2008
From: VIALLET, JEAN
To: GEMIN X PHARMACEUTICALS CANADA INC.
Reel/Frame 020450/0236 →
Change of Name
Jan 31, 2008
From: ATTARDO, GIORGIO; DAIRI, KENZA; LAVALLEE, JEAN-FRANCOIS; RIOUX, ELISE
To: GEMIN X PHARMACEUTICALS CANADA INC.
Reel/Frame 020450/0286 →
Change of Name
Jan 31, 2008
From: VIALLET, JEAN
To: GEMIN X PHARMACEUTICALS CANADA INC.
Reel/Frame 020450/0270 →
Assignment of Assignor's Interest
May 27, 2008
From: ATTARDO, GIORGIO; TRIPATHY, SASMITA; RIOUX, ELISE; GONZALEZ, GERSON
To: GEMIN X PHARMACEUTICALS CANADA INC.
Reel/Frame 020999/0373 →
Change of Name
Jun 4, 2008
From: GEMINX BIOTECHNOLOGIES INC.
To: GEMINX PHARMACEUTICALS CANADA INC.
Reel/Frame 021029/0922 →